Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Read More…
Industry, Sector and Symbol
Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
SectorMulti-Sector Conglomerates
Phone202-828-0850
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$17.91 billion
Profitability
Miscellaneous
Employees71,000
Next Earnings Date4/16/2020 (Estimated)
OptionableOptionable
Danaher (NYSE:DHR) Frequently Asked Questions
What is Danaher's stock symbol?
Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."
How often does Danaher pay dividends? What is the dividend yield for Danaher?
Danaher declared a quarterly dividend on Thursday, February 20th. Shareholders of record on Friday, March 27th will be paid a dividend of $0.18 per share on Friday, April 24th. This represents a $0.72 annualized dividend and a yield of 0.44%. This is an increase from Danaher's previous quarterly dividend of $0.17. View Danaher's Dividend History.
How were Danaher's earnings last quarter?
Danaher Co. (NYSE:DHR) issued its earnings results on Thursday, January, 30th. The conglomerate reported $1.28 EPS for the quarter, topping the consensus estimate of $1.25 by $0.03. The conglomerate had revenue of $4.87 billion for the quarter, compared to analyst estimates of $4.80 billion. Danaher had a net margin of 15.09% and a return on equity of 11.50%. The business's revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the business earned $1.28 earnings per share. View Danaher's Earnings History.
When is Danaher's next earnings date?
What guidance has Danaher issued on next quarter's earnings?
Danaher issued an update on its FY20 earnings guidance on Thursday, January, 30th. The company provided earnings per share (EPS) guidance of $4.80 to $4.90 for the period, compared to the Thomson Reuters consensus estimate of $5.38.
What price target have analysts set for DHR?
17 brokerages have issued 12-month price objectives for Danaher's shares. Their forecasts range from $130.00 to $195.00. On average, they anticipate Danaher's stock price to reach $166.28 in the next twelve months. This suggests a possible upside of 2.7% from the stock's current price. View Analyst Price Targets for Danaher.
What is the consensus analysts' recommendation for Danaher?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 4 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Danaher.
Has Danaher been receiving favorable news coverage?
Media stories about DHR stock have been trending positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Danaher earned a news sentiment score of 2.6 on InfoTrie's scale. They also gave press coverage about the conglomerate a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Danaher.
Are investors shorting Danaher?
Danaher saw a decline in short interest during the month of January. As of January 31st, there was short interest totalling 9,650,000 shares, a decline of 13.9% from the January 15th total of 11,210,000 shares. Based on an average daily volume of 11,060,000 shares, the short-interest ratio is presently 0.9 days. Currently, 1.5% of the company's shares are sold short. View Danaher's Current Options Chain.
Who are some of Danaher's key competitors?
Some companies that are related to Danaher include Roper Technologies (ROP), Fortive (FTV), Keysight Technologies (KEYS), Cognex (CGNX), Sensata Technologies (ST), MKS Instruments (MKSI), Mesa Laboratories (MLAB), Rudolph Technologies (RTEC), Hurco Companies (HURC), Hickok (HICKA), Crawford United (CRAWA), Clearsign Combustion (CLIR), International Isotopes (INIS), Sypris Solutions (SYPR) and Schmitt Industries (SMIT).
What other stocks do shareholders of Danaher own?
Who are Danaher's key executives?
Danaher's management team includes the folowing people:
- Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 58)
- Mr. Daniel L. Comas, Exec. VP (Age 55)
- Mr. William K. Daniel II, Exec. VP (Age 54)
- Mr. Rainer M. Blair, Exec. VP (Age 55)
- Mr. Joakim Weidemanis, Exec. VP (Age 49)
Who are Danaher's major shareholders?
Danaher's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (1.32%), Capital International Investors (0.86%), Bank of New York Mellon Corp (0.77%), Goldman Sachs Group Inc. (0.74%), Janus Henderson Group PLC (0.73%) and UBS Asset Management Americas Inc. (0.69%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher.
Which institutional investors are selling Danaher stock?
DHR stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, 1832 Asset Management L.P., Marshall Wace North America L.P., AQR Capital Management LLC, UBS Asset Management Americas Inc., Marshall Wace LLP, Commerzbank Aktiengesellschaft FI and Prudential Financial Inc.. Company insiders that have sold Danaher company stock in the last year include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher.
Which institutional investors are buying Danaher stock?
DHR stock was purchased by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Janus Henderson Group PLC, Madison Asset Management LLC, Loomis Sayles & Co. L P, Geode Capital Management LLC, Fred Alger Management LLC, Beacon Investment Advisory Services Inc. and Arthur M. Cohen & Associates LLC. View Insider Buying and Selling for Danaher.
How do I buy shares of Danaher?
Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Danaher's stock price today?
One share of DHR stock can currently be purchased for approximately $161.88.
How big of a company is Danaher?
Danaher has a market capitalization of $116.28 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis. Danaher employs 71,000 workers across the globe.View Additional Information About Danaher.
What is Danaher's official website?
How can I contact Danaher?
Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]
MarketBeat Community Rating for Danaher (NYSE DHR)
MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote "Outperform" if you believe DHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.
